Literature DB >> 16396741

Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala.

Anna K Läck1, Donald W Floyd, Brian A McCool.   

Abstract

Withdrawal anxiety following chronic ethanol exposure is often associated with relapse in recovering alcoholics. It is likely that brain regions regulating anxiety-like behaviors adapt during chronic ethanol exposure to ultimately regulate such behaviors. The central amygdala contains numerous neurotransmitter systems that have been implicated in the regulation of anxiety-like behavior, including corticotropin releasing factor (CRF) and NMDA-type glutamate receptors. Chronic ethanol exposure causes functional adaptations in both CRF and NMDA receptors that are likely to regulate anxiety-like behaviors expressed during withdrawal. However, the molecular mechanisms governing these adaptations remain unexplored. We therefore evaluated these neurotransmitter systems in Sprague-Dawley rats during chronic ingestion of an ethanol-containing liquid diet. Quantitative real-time reverse transcription-PCR demonstrated that preproCRF mRNA was significantly upregulated by chronic ethanol exposure, whereas mRNA expression of CRF binding protein did not change. There were also no significant changes observed in any of the NMDA subunit mRNAs, although there was a trend toward greater NR2A mRNA expression during chronic ethanol exposure. Using Western blotting analysis we measured NMDA receptor subunit protein expression. Chronic ethanol exposure did not affect protein levels of the NR1 and NR2B subunits. Like the mRNA measures, chronic ethanol exposure did influence NR2A protein levels but the effects were modest. Our results demonstrate that NMDA receptor subunit mRNA and protein expressions are not strongly influenced by exposure to chronic ethanol. This suggests that the functional NMDA receptor adaptations identified in previous studies [Roberto, M., Schweitzer, P., Madamba, S. G., Stouffer, D. G., Parsons, L. H., & Siggins, G. R. (2004). Acute and chronic ethanol exposure alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J Neurosci 24, 1594-1603] are likely to be mediated by post-translational events. In contrast, enhanced levels of CRF during/after chronic ethanol exposure are likely to be mediated by increased levels of prepro CRF mRNA. Together, our findings suggest that adaptations to chronic ethanol exposure by proanxiety factors expressed in the central nucleus appear to be mediated by distinct cellular and molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16396741      PMCID: PMC1557647          DOI: 10.1016/j.alcohol.2005.07.004

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  44 in total

1.  Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal.

Authors:  K Gulya; K A Grant; P Valverius; P L Hoffman; B Tabakoff
Journal:  Brain Res       Date:  1991-04-26       Impact factor: 3.252

2.  Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.

Authors:  D A Myers; J V Trinh; T R Myers
Journal:  Mol Cell Endocrinol       Date:  1998-09-25       Impact factor: 4.102

3.  Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats.

Authors:  Rita A Fuchs; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2002-02-14       Impact factor: 4.530

4.  Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.

Authors:  T J Sajdyk; D A Schober; D R Gehlert; A Shekhar
Journal:  Behav Brain Res       Date:  1999-04       Impact factor: 3.332

5.  Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal.

Authors:  S.C. Heinrichs; F. Menzaghi; G. Schulteis; G.F. Koob; L. Stinus
Journal:  Behav Pharmacol       Date:  1995-01       Impact factor: 2.293

6.  Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test.

Authors:  S Shibata; K Yamashita; E Yamamoto; T Ozaki; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

8.  Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons.

Authors:  Mark A Ungless; Vineeta Singh; Tara L Crowder; Rami Yaka; Dorit Ron; Antonello Bonci
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

9.  Long-term ethanol self-administration by cynomolgus macaques alters the pharmacology and expression of GABAA receptors in basolateral amygdala.

Authors:  Donald W Floyd; David P Friedman; James B Daunais; Peter J Pierre; Kathleen A Grant; Brian A McCool
Journal:  J Pharmacol Exp Ther       Date:  2004-07-27       Impact factor: 4.030

10.  Effects of chronic ethanol consumption on rat GABA(A) and strychnine-sensitive glycine receptors expressed by lateral/basolateral amygdala neurons.

Authors:  Brian A McCool; Gerald D Frye; Marisa D Pulido; Shaleen K Botting
Journal:  Brain Res       Date:  2003-02-14       Impact factor: 3.252

View more
  37 in total

Review 1.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

Review 2.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

Review 3.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

Review 4.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

5.  Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking.

Authors:  Daniel T Christian; Nancy J Alexander; Marvin R Diaz; Stacey Robinson; Brian A McCool
Journal:  Neuropharmacology       Date:  2012-02-22       Impact factor: 5.250

6.  Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice.

Authors:  Emily G Lowery-Gionta; Montserrat Navarro; Chia Li; Kristen E Pleil; Jennifer A Rinker; Benjamin R Cox; Gretchen M Sprow; Thomas L Kash; Todd E Thiele
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

Review 7.  Molecular tools to elucidate factors regulating alcohol use.

Authors:  Marian L Logrip
Journal:  Alcohol       Date:  2018-03-20       Impact factor: 2.405

8.  Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex.

Authors:  Maile A Henson; Adam C Roberts; Kayvon Salimi; Swarooparani Vadlamudi; Robert M Hamer; John H Gilmore; L Fredrik Jarskog; Benjamin D Philpot
Journal:  Cereb Cortex       Date:  2008-02-21       Impact factor: 5.357

Review 9.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

10.  Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm.

Authors:  Georgina Valeria Fernández Macedo; María Laura Cladouchos; Laura Sifonios; Pablo Martín Cassanelli; Silvia Wikinski
Journal:  Psychopharmacology (Berl)       Date:  2012-09-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.